If the FDA says yes, a major new weight loss drug may hit the market this year. A high-dose formulation of liraglutide, the popular diabetes drug from Novo Nordisk, melts up to 10 percent of body mass, studies show.
Liraglutide, available in 1.2 mg and 1.8 mg doses as Victoza, is already a huge success for Novo Nordisk. The company has now filed with the FDA seeking approval for a 3.0 mg dose after studies found major weight loss benefits (in conjunction with diet and exercise.)
Hey, check out all the research scientist jobs. Post your resume today!
